Why rare-disease drugs could become India’s next pharma frontier – The Hindu
Why rare-disease drugs could become India’s next pharma frontier The Hindu Read the full story at…
Why rare-disease drugs could become India’s next pharma frontier The Hindu Read the full story at…
Brazil's historic match against India in Kolkata lacked the usual frenzy, as local excitement was…
India should join ICH, restore Weighted R&D tax deduction to drive Innovation: Zydus’ Pankaj Patel ETPharma.com…
His father Dayanand, a former India wrestler in Greco Roman, focused on technique early on…
Backward Linkage between Pharma Giants & Pharma MSMEs in India The Financial World Read the full…
A victory for the defending champions will earn them a direct berth to the LA…
America Wants to Make More Generic Drugs. India Shows Why That’s Hard. The New York Times…
Kerala Medical Services Corporation Limited released only the drug supplies of the first quarter and that…
The next phase of raids will focus on antiretroviral drugs, higher-generation and critical antibiotics, medical…
Since joining the founding faculty of AIIMS New Delhi, he has never stopped working at…